Roche Pharma India expands partnership with Cipla for key oncology medicines

Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distribution of its trademark oncology drugs - trastuzumab (Herclon), bevacizumab (Avastin) and rituximab (Ristova) in India," the company said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dbJtm8
via IFTTT